Company AB Science Deutsche Boerse AG

A8D

FR0010557264

Pharmaceuticals

Real-time Estimate Tradegate 14:25:16 2026-08-31 EDT			5-day change	1st Jan Change
0.7010 ^EUR	-3.31%		+4.67%	-47.43%

08-17	AB Science completes settlement and delivery of its private placement
08-10	AB Science Wraps Up EUR14 Million Private Placements	MT

Business description: AB Science

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 31

Sales by Activity: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Pharmaceuticals	1.61M	958K	970K	1.07M	1.17M

See all business segments

Geographical breakdown of sales: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Europe	-	-	-	-	955K
outside Europe	-	-	-	-	219K

See all geographic segments

Executive Committee: AB Science

Manager	Title	Age	Since
Stéphane Ledermann CEO	Chief Executive Officer	-	2026-07-06
Laurent Guy DFI	Director of Finance/CFO	-	2009-11-19
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	2018-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

See AB SCIENCE governance

Composition of the Board of Directors: AB Science

Director	Title	Age	Since
Alain Moussy CHM	Chairman	-	2001-07-10
Patrick Moussy BRD	Director/Board Member	-	2011-09-19
Cécile de Guillebon BRD	Director/Board Member	64	2021-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	68	2021-06-26
Guillemette Latscha BRD	Director/Board Member	-	2021-06-26
Stéphane Ledermann CHM	Chairman	-	2026-07-06

Composition of the Board of Directors

Shareholders: AB Science

Name	Stocks	%	Valuation
Gestys SA 0.0205 %	15,000	0.0205 %	9 337 €
UBS Wealth Management SGIIC SA 0.004232 %	3,100	0.004232 %	1 930 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 5.198 %	85,471	5.198 %	32 845 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 4.167 %	64,103	4.167 %	20 208 €

List of AB SCIENCE shareholders

Company details: AB Science

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MERCK & CO., INC.	-0.47%	-1.89%	+72.93%	+35.64%	366B
MERCK KGAA	-0.89%	+0.43%	+27.87%	-16.27%	70.76B
HALOZYME THERAPEUTICS, INC.	+0.81%	-2.03%	+45.13%	+150.09%	11.96B
KYOWA KIRIN CO., LTD.	-1.33%	+2.00%	+3.26%	-1.02%	8.72B
SK BIOPHARMACEUTICALS CO., LTD.	-0.80%	+4.30%	-11.46%	+0.92%	5B
YUHAN CORPORATION	-1.41%	+1.70%	-26.26%	+21.05%	4.59B
BETTA PHARMACEUTICALS CO., LTD.	-0.14%	-1.37%	-28.57%	+2.92%	3.16B
SUPERNUS PHARMACEUTICALS, INC.	+0.25%	-2.93%	-1.68%	+37.53%	2.54B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-2.27%	-3.75%	-17.97%	-14.26%	2.08B
Average	-0.71%	-0.19%	+7.03%	+24.07%	52.76B
Weighted average by Cap.	-0.55%	-1.86%	+60.91%	+29.18%